<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7220586\results\search\testTrace\results.xml">
  <result pre="to understand the individual, regional and ethnic variations in disease" exact="prevalence" post="and course. Subject terms Diabetes complications Epidemiology Background The"/>
  <result pre="and course. Subject terms Diabetes complications Epidemiology Background The high" exact="prevalence" post="of diabetes globally makes it a frequent comorbidity in"/>
  <result pre="coronavirus-associated disease 2019 (COVID-19). Though diabetes increases the risk of" exact="infection" post="in general, most studies have reported prevalence of diabetes"/>
  <result pre="the risk of infection in general, most studies have reported" exact="prevalence" post="of diabetes almost similar to that in general population"/>
  <result pre="present in 8% of 46,248 patients with COVID-19 [1]. Understandably," exact="prevalence" post="of diabetes in patients with COVID-19 varies by region,"/>
  <result pre="with well-controlled blood glucose levels have an increased risk of" exact="infection" post="with severe acute respiratory syndrome coronavirus 2 (SARS CoV-2)."/>
  <result pre="response to viral infections and to the potential secondary bacterial" exact="infection" post="in the lungs [6, 7]. Defects in immunity namely"/>
  <result pre="interferon, which may further impair immunity and predispose to severe" exact="infection" post="[10]. Further, diabetes is associated with increased plasminogen levels"/>
  <result pre="further worsen the prognosis. Lastly, hypoglycaemia which could occur during" exact="treatment" post="of diabetes may additionally worsen the clinical outcomes. Table"/>
  <result pre="drugs: correct selection and potential problems The precise effect of" exact="treatment" post="with various oral anti-hyperglycaemic agents on the severity of"/>
  <result pre="intensive care would need insulin for glycaemic control. Drugs for" exact="treatment" post="of comorbidities in diabetes Angiotensin converting enzyme (ACE) inhibitors/angiotensin"/>
  <result pre="with ARBs was reported to reduce mortality in Ebola virus" exact="infection" post="[27]. Previously, a small study in ten patients with"/>
  <result pre="patients with diabetes? The natural course of the disease after" exact="infection" post="of patients with diabetes with SARS CoV-2 has not"/>
  <result pre="longer period than those without diabetes. Use of drugs in" exact="treatment" post="of COVID-19 which could have effect on glycaemia: Chloroquine"/>
  <result pre="the pandemic. This poses some challenges in the evaluation and" exact="treatment" post="of patients with diabetes. There are limited opportunities for"/>
  <result pre="chest pain, weakness of limbs, altered sensorium, etc [43]. COVID-19" exact="testing" post="for all patients with diabetes? Given the increased severity"/>
  <result pre="in patients with diabetes, a case could be made for" exact="testing" post="of all people with diabetes for the presence of"/>
  <result pre="disease. That would be a humongous task considering the high" exact="prevalence" post="of diabetes. High-risk groups like those with high HbA1c,"/>
  <result pre="be proven, There are frequent false negative tests and repeated" exact="testing" post="may be required in asymptomatic individuals. Since there is"/>
  <result pre="may be required in asymptomatic individuals. Since there is no" exact="treatment" post="currently recommended for asymptomatic people, therefore apart from isolating"/>
  <result pre="will be of interest, considering the racial disparities in the" exact="prevalence" post="of diabetes. According to a recent report, prevalence of"/>
  <result pre="in the prevalence of diabetes. According to a recent report," exact="prevalence" post="of COVID-19 and mortality due to the disease correlated"/>
  <result pre="people with well-controlled diabetes at higher risk of getting COVID-19" exact="infection" post="than non-diabetic individuals? (2) Is there any effect of"/>
  <result pre="coronary artery disease patients is reduced by dapagliflozin treatmentAtherosclerosis2020292606910.1016/j.atherosclerosis.2019.11.01631783199 23.SalemESBGrobeNElasedKMInsulin" exact="treatment" post="attenuates renal ADAM17 and ACE2 shedding in diabetic Akita"/>
  <result pre="in the clinical presentation and management of patients with COVID-19" exact="infection" post="with reference to use of therapeutic and other drugs"/>
  <result pre="of a familial clusterClin Immunol2020214108413.10.1016/j.clim.2020.10841332276139 38.SinghAKSinghAShaikhASinghRMisraAChloroquine and hydroxychloroquine in the" exact="treatment" post="of COVID-19 with or without diabetes: a systematic search"/>
  <result pre="Res202028811295810.1016/j.psychres.2020.11295832283450 41.GhosalSSinhaBMajumderMMisraAEstimation of effects of nationwide lockdown for containing coronavirus" exact="infection" post="on worsening of glycosylated haemoglobin and increase in diabetes-related"/>
 </snippets>
</snippetsTree>
